Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial.
Sesay S, Brzostek J, Meyer I, Donazzolo Y, Leroux-Roels G, Rouzier R, Astruc B, Szymanski H, Toursarkissian N, Vandermeulen C, Kowalska E, Van Damme P, Salamand C, Pepin S. Sesay S, et al. Among authors: donazzolo y. Hum Vaccin Immunother. 2018 Mar 4;14(3):596-608. doi: 10.1080/21645515.2017.1384106. Epub 2017 Nov 27. Hum Vaccin Immunother. 2018. PMID: 28968138 Free PMC article. Clinical Trial.
Immunogenicity and safety of the Southern Hemisphere 2015 formulation of Vaxigrip®.
Latreille-Barbier M, Rouzier R, Astruc B, Lavis N, Donazzolo Y. Latreille-Barbier M, et al. Among authors: donazzolo y. Hum Vaccin Immunother. 2017 Nov 2;13(11):2674-2677. doi: 10.1080/21645515.2017.1363944. Epub 2017 Sep 22. Hum Vaccin Immunother. 2017. PMID: 28937844 Free PMC article. Clinical Trial.
A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab for pre-exposure use in healthy adults: results from a randomized controlled phase-II trial.
Pichon S, Guinet-Morlot F, Minutello M, Donazzolo Y, Rouzier R, Chassard D, Fitoussi S, Hou V. Pichon S, et al. Among authors: donazzolo y. Vaccine. 2013 Apr 26;31(18):2295-301. doi: 10.1016/j.vaccine.2013.02.058. Epub 2013 Mar 16. Vaccine. 2013. PMID: 23510665 Clinical Trial.
Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial.
Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. Ibarra A, et al. Among authors: donazzolo y. Gut Microbes. 2018;9(3):236-251. doi: 10.1080/19490976.2017.1412908. Epub 2018 Feb 8. Gut Microbes. 2018. PMID: 29227175 Free PMC article. Clinical Trial.
Evaluation of the effects of therapeutic and supratherapeutic doses of agomelatine on the QT/QTc interval: a phase I, randomized, double-blind, placebo-controlled and positive-controlled, crossover thorough QT/QTc study conducted in healthy volunteers.
Donazzolo Y, Latreille M, Caillaud MA, Mocaer E, Seguin L. Donazzolo Y, et al. J Cardiovasc Pharmacol. 2014 Nov;64(5):440-51. doi: 10.1097/FJC.0000000000000136. J Cardiovasc Pharmacol. 2014. PMID: 24977347 Clinical Trial.
39 results